BRIEF published on 01/20/2026 at 15:58, 9 months 2 days ago Kopernik Global Investors crosses thresholds at EUROAPI Voting Rights Actions Crossing Thresholds EUROAPI Kopernik Global Investors
BRIEF published on 12/10/2025 at 17:50, 10 months 12 days ago Tristan Imbert Appointed as Independent Director at EUROAPI Pharmaceutical Industry Independent Director Audit Committee EUROAPI Tristan Imbert
PRESS RELEASE published on 12/10/2025 at 17:45, 10 months 12 days ago Tristan Imbert co-opted as Independent Director Tristan Imbert appointed Independent Director at EUROAPI, bringing expertise in pharmaceutical finance and strategy. Financial agenda includes FY 2025 results on 3 March 2026 and 2026 AGM on 27 May 2026 Financial Agenda Strategy EUROAPI Tristan Imbert Pharmaceutical Finance
BRIEF published on 09/18/2025 at 07:05, 1 year 1 month ago Science Based Targets initiative Validates EUROAPI's Climate Goals Sustainability GHG Emissions EUROAPI Climate Goals SBTi Validation
PRESS RELEASE published on 09/18/2025 at 07:00, 1 year 1 month ago Science Based Targets initiative (SBTi) validates EUROAPI’s near-term climate targets EUROAPI's near-term climate targets validated by the Science Based Targets initiative (SBTi) show significant reductions in greenhouse gas emissions, confirming alignment with the Paris Agreement Greenhouse Gas Emissions Science Based Targets Initiative Climate Targets Paris Agreement EUROAPI
BRIEF published on 06/30/2025 at 18:03, 1 year 3 months ago EUROAPI Divests Haverhill Site to Particle Dynamics Pharmaceutical EUROAPI FOCUS-27 Haverhill Sale Particle Dynamics
PRESS RELEASE published on 06/30/2025 at 17:58, 1 year 3 months ago EUROAPI sells Haverhill site to Particle Dynamics as part of its FOCUS-27 transformation plan EUROAPI sells Haverhill site to Particle Dynamics as part of its FOCUS-27 transformation plan. Deal strengthens capabilities, market reach Acquisition EUROAPI FOCUS-27 Particle Dynamics Haverhill
BRIEF published on 06/19/2025 at 16:29, 1 year 4 months ago Goldman Sachs Crosses Thresholds in EUROAPI Voting Rights Actions Goldman Sachs Threshold Crossing EUROAPI
BRIEF published on 06/06/2025 at 16:03, 1 year 4 months ago EUROAPI General Assembly: Approval of Resolutions and Perspectives General Assembly EUROAPI Resolutions Approved R&D And CDMO Outlook 2023
BRIEF published on 06/04/2025 at 17:50, 1 year 4 months ago EUROAPI appoints Frédéric Robert as Sales Director for API and CDMO CDMO Appointment EUROAPI Frédéric Robert API Solutions
Published on 10/23/2026 at 02:20, 9 hours 43 minutes ago Apex Announces Nasdaq Listing and Pricing of US$1.86 Million Offering
Published on 10/22/2026 at 23:30, 12 hours 33 minutes ago Cypher Announces Subscription Receipt Offering
Published on 10/22/2026 at 22:30, 13 hours 33 minutes ago Unusual Machines to Announce Third Quarter 2026 Financial Results and Provide Corporate Update
Published on 10/22/2026 at 16:00, 20 hours 3 minutes ago Future Fuels Announces Closing of Brokered Offering for Gross Proceeds of C$6.6 Million
Published on 10/22/2026 at 14:30, 21 hours 33 minutes ago Unusual Machines Receives $16.9 Million Purchase Order from Powerus for American-Made Drone Components
Published on 10/23/2026 at 11:45, 18 minutes ago Original-Research: Grand City Properties SA (von First Berlin Equity Research GmbH): Kaufen
Published on 10/23/2026 at 11:30, 33 minutes ago Bulgarian Financial Supervision Commission completes preliminary review of the voluntary public takeover offer for Shelly Group SE
Published on 10/23/2026 at 11:30, 33 minutes ago Acceptance period of Sazerac’s voluntary public takeover offer for Berentzen-Gruppe Aktiengesellschaft commences
Published on 10/23/2026 at 11:00, 1 hour 3 minutes ago Annual General Meeting Approves Contribution: Innok Robotics on Course for the Public Capital Market
Published on 10/22/2026 at 18:00, 18 hours 3 minutes ago THERMADOR GROUPE : Completion of the share buy-back programme launched in August
Published on 10/22/2026 at 18:00, 18 hours 3 minutes ago bioMérieux receives Dual 510(k) Clearance and CLIA Waiver from the FDA for the BIOFIRE® SPOTFIRE® Vaginitis Panel to Advance Women’s Health with Rapid Molecular Diagnostics
Published on 10/22/2026 at 18:00, 18 hours 3 minutes ago H1 2026: marked improvement in operating results
Published on 10/22/2026 at 17:47, 18 hours 16 minutes ago Aéroports de Paris SA - 2026 9-month revenue
